Schreck Michael 4

What Happened
Michael Schreck, Executive Vice President of IDEXX Laboratories (IDXX), had a set of restricted stock units (RSUs) granted on Feb 12, 2026, and a portion of those RSUs converted/settled into common shares on Feb 14, 2026. Total RSUs granted on Feb 12 amounted to 7,501 units (4,625 + 162 + 1,094 + 1,620). On Feb 14, a total of 1,959 derivative units (117 + 169 + 301 + 367 + 1,005) were converted/settled into shares at $0.00 per share (typical for RSU vesting/conversion). To cover tax withholding related to the vesting, 876 shares were withheld/disposed at $629.35 per share, totaling $551,311. Net shares delivered to Schreck after withholding were 1,083 shares (1,959 converted − 876 withheld).

Key Details

• Transaction dates: Grants on 2026-02-12; conversions/settlements and withholding on 2026-02-14. Form 4 filed 2026-02-17 (appears timely).
• Prices/values: RSUs/settlements recorded at $0.00 per share (derivative conversion); tax withholding sale recorded at $629.35 per share, total $551,311.
• Shares after transaction: Not stated in the provided filing excerpt.
• Notable footnotes: Some RSUs vest in annual installments beginning Feb 14, 2026 (footnotes F10–F11 explain vesting schedules; F11 indicates some RSUs vested in one installment on Feb 14, 2026). F1 notes prior Employee Stock Purchase Plan purchases are included in holdings.
• Transaction codes: A = award/grant of RSUs, M = conversion/exercise of derivative (RSU settlement), F = shares withheld to satisfy tax liability. These withholdings are routine (tax-related), not open-market sales.

Context
This was primarily an RSU grant and subsequent vest/settlement event with shares withheld to cover taxes — effectively a cashless/net share settlement. Such withholdings are standard and do not necessarily indicate the insider is selling shares for investment reasons. The Form 4 appears to have been filed within the normal SEC timing window.